Skip to content

Economic Calendar Earnings Calendar MakklerPRO

Log In Get Started Free

Overview Stocks Crypto Currencies Commodities ETFs Options Guru Portfolios My watchlist

Makkler App

Faster and clearer

Skip to content

Economic Calendar Earnings Calendar MakklerPRO

Log In Get Started Free

Overview/Stocks/A

Agilent Technologies, Inc. A

NYSEHealth TechnologyUnited States

$173.96+0.95 (+0.55%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 170.71174.62
52-week range: 108.35182.99

Financial health

– / 5

Analyst view · 25 firms

Buy17 buy · 8 hold · 0 sell

Avg. target $184.11 (+5.8%)

Overview Financials Analysis Earnings Dividends Technicals Historical data News

Prices may be delayed and are for informational purposes only - not investment advice.

Makkler news

StockStory Cites Debt, Margins and Growth at Three Healthcare Firms

The publisher points to weakening margins, modest growth and low returns on capital in its assessments of BioMarin, STERIS and Agilent.

Makkler Newsroom · Sep 28, 12:44 PM · 1 min read

Company news

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Nov 12, 2026
Agilent Technologies (A) Launches New Cancer Panel As Valuation Stays In FocusYahoo Finance
Nov 12, 2026
Agilent to Participate in 9th Annual Evercore Healthcare ConferenceYahoo Finance
Nov 12, 2026
What Happened To People Who Bought Thermo Fisher Stock At A High?Yahoo Finance
Nov 12, 2026
Learn Why The Bull Case For Agilent Stock Could Change Following Pan Heme LaunchYahoo Finance
Nov 12, 2026
Agilent Technologies (A) Expands Tumor Profiling With New Pan Heme Research PanelYahoo Finance
Nov 12, 2026
Aveanna Healthcare (AVAH) Q3 Earnings and Revenues Beat EstimatesZacks
Nov 11, 2026
Is Illumina Stock Worth The Wait?Yahoo Finance
Nov 11, 2026
Mass Spectrometry - Global Strategic Business Report 2026-2032 Featuring Thermo Fisher, Agilent, Bruker, Shimadzu, Waters and MoreYahoo Finance
Nov 11, 2026
RNA Analysis / Transcriptomics - Global Strategic Business Report: Capitalize on 13.4% CAGR to $19B by 2030 as Agilent, Beckman Coulter, bioMerieux, BGI Genomics, and 10X Genomics AccelerateYahoo Finance
Nov 11, 2026
Single-Cell Analysis - Global Strategic Business Report 2026: Capitalize on 20.4% CAGR as Illumina, Thermo Fisher Scientific, Bio-Rad and Agilent Battle for Shares in the $26.1 Billion Market by 2032Yahoo Finance
Nov 11, 2026
Molecular Cytogenetics - Global Strategic Business Report: Capitalize on 8.8% CAGR to US$3.5 Billion by 2030; Outmaneuver Abbott, Agilent, Bio-Rad, Illumina and Roche Amid Tariff ShiftsYahoo Finance
Nov 11, 2026
Genetic Testing - Global Strategic Business Report: Secure Share of a US$26.4 Billion Market by 2030 as Agilent Technologies, Asuragen, Biocartis, and Agena Bioscience AccelerateYahoo Finance
Nov 10, 2026
Capillary Electrophoresis - Global Strategic Business Report: Secure Share of the $1.1 Billion Market by 2032 as Agilent, Bio-Rad, Danaher and Thermo Fisher Accelerate CE-MS InnovationYahoo Finance
Nov 10, 2026
Electrophoresis Reagents - Global Strategic Business Report: Capitalize on China's 7.4% CAGR as Bio-Rad, QIAGEN, Agilent, Merck Millipore and Thermo Fisher Battle for $1.3B by 2032Yahoo Finance
Nov 10, 2026
Gene Panels - Global Strategic Business Report 2026: Capitalize on 17.9% CAGR as Market Triples to $12.6B by 2032 - Track Key Players Illumina, Roche, QIAGEN, Thermo Fisher, Agilent and MoreYahoo Finance
Nov 10, 2026
Agilent Expands Tumor Profiling Portfolio with SureSelect Cancer Research Pan HemeYahoo Finance
Nov 9, 2026
Structural Biology and Molecular Modeling Techniques - Global Strategic Business Report 2026: Capitalize on the $18 Billion 2032 Market with Agilent, Bruker Daltonics, Dassault Systemes, and IlluminaYahoo Finance
Nov 9, 2026
Global Arrayed CRISPR Screening Market Report 2026 | Capitalize on 17.7% CAGR to $3.43 Billion as Thermo Fisher, Merck, Agilent and GenScript Advance Precision Drug DiscoveryYahoo Finance
Nov 6, 2026
Global Oligonucleotide Synthesis Services Market Report 2026 | Capitalize on $4.7B by 2030 as Thermo Fisher, Agilent, QIAGEN and IDT Accelerate GMP and CRISPR CapacityYahoo Finance
Nov 5, 2026
Q-TOF Mass Spectrometry - Global Strategic Business Report 2026: Capitalize on 8.9% CAGR to $1.3 Billion by 2032 as AB SCIEX, Agilent, Bruker, Thermo Fisher Scientific and Waters Battle for ShareYahoo Finance

News alerts

Use the bell at the top of the page to be notified when there is new A news.

Guru Portfolios

See with MakklerPRO

The portfolio-sharing platform connecting finance analysts with an audience that wants to learn.

Markets

All markets
Stocks
Crypto
Currencies
Commodities
ETFs
My watchlist

Research

News
Economic Calendar
Earnings Calendar
MakklerAI
Famous Investors

Community

Clubs

Company

Legal

Popular searches

Indices

Borsa Istanbul

US stocks

FX and commodities

Crypto

© 2026 Makkler, LLC. All rights reserved. Content on this platform does not constitute investment advice.

Prices may be delayed depending on the data source.

Makkler, LLC · 30 N Gould St, STE R, Sheridan, WY 82801, United States

Language

Theme

Your research starts here.

Become an Analyst

Terms of Service

Data Protection Notice

Risk Disclosure

THYAOTurkish Airlines

GARANGaranti BBVA

KCHOLKoç Holding